Newmont Corporation
NYSE:NEMGold
-$2.45 today
- Market cap
- $108.63B
- Beta
- 0.46
- P/E (TTM)
- 13.2
- EPS (TTM)
- $7.79
- Dividend yield
- 0.99%
Volume 8.52M
Average 8.93M
NEM Sales of Investments
Cash received from selling or redeeming investments.
Newmont CorporationNYSE: NEM
Sales of Investments · Q3 FY2026 · quarter ended Sep 2026
Sales of investments outflow shrinks to $0
Q3 FY2026 sales of investments was $0, compared with $589M a year earlier. Trailing-twelve-month sales of investments was $298M. Over 3 fiscal years it compounded at +58.3% a year.
Context
- Sales of investments amounted to 4.6% of revenue in FY2025, up 4.4 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $74.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 1.05B USD
- Year-over-year change
- +2038.8%
- 4-year CAGR
- +49.1%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.05B | +2038.8% |
| FY2024 | 2024-12-31 | 49M | -97.0% |
| FY2023 | 2023-12-31 | 1.63B | +518.6% |
| FY2022 | 2022-12-31 | 264M | +24.5% |
| FY2021 | 2021-12-31 | 212M | — |
Sales of Investments vs competitors
How NEM compares with its peers on the latest reported figures
- Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -69.7% is the 5th highest of 7, against a peer median of +6.9%.
- Sales of investments amounts to 1.1% of revenue for NEM, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $884.74M USD | +1463.1% | +738.6% | 10.1% | |
| LTM Jun 2026 | $502.17M USD | +870.2% | -1.8% | 2.4% | |
| LTM Jun 2026 | $404.32M USD | — | — | 2.8% | |
| LTM Sep 2026 | $298M USD | -69.7% | +58.3% | 1.1% | |
| LTM Jun 2026 | $217.4M USD | — | — | 2.6% | |
| LTM Sep 2026 | $148.11M USD | +63.0% | — | 1.2% | |
| LTM Jun 2026 | $51.84M USD | -49.3% | — | 1.4% | |
| LTM Jun 2026 | $20.38M USD | -87.3% | — | 1.0% | |
| LTM Jun 2026 | $1.74M USD | -120.4% | +21.4% | 0.0% | |
| FY2026 | ZAR 961.77K ZAR | — | -74.5% | 0.0% | |
| Peer median (excluding NEM) | — | +6.9% | +9.8% | 1.4% | |
Competitors are the stored peer set for NEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.17B | (399M) | (2.47B) | 3.38B | 7.17B |
| Depreciation & Amortization | 2.45B | 2.19B | 2.11B | 2.58B | 2.52B |
| Deferred Income Tax | (109M) | (278M) | (104M) | 80M | 1.39B |
| Stock-Based Compensation | 72M | 73M | 80M | 89M | 99M |
| Change in Working Capital | (541M) | (841M) | (513M) | (1.03B) | (1.01B) |
| Accounts Receivables | 142M | 5M | (240M) | (441M) | (930M) |
| Inventory | (136M) | (161M) | (187M) | (534M) | (454M) |
| Accounts Payables | (11M) | 102M | (42M) | (2M) | (19M) |
| Other Working Capital | (536M) | (787M) | (44M) | (48M) | 397M |
| Other Non-Cash Items | 1.24B | 2.48B | 3.66B | 1.26B | 162M |
| Operating Cash Flow | 4.28B | 3.22B | 2.76B | 6.36B | 10.33B |
| Capital Expenditures | (1.65B) | (2.13B) | (2.67B) | (3.4B) | (3.04B) |
| Acquisitions (Net) | (228M) | (147M) | 668M | (40M) | 2.94B |
| Purchases of Investments | (209M) | (940M) | (659M) | (66M) | (73M) |
| Sales of Investments | 212M | 264M | 1.63B | 49M | 1.05B |
| Other Investing Activities | 110M | (29M) | 22M | 757M | (145M) |
| Investing Cash Flow | (1.77B) | (2.98B) | (1B) | (2.7B) | 739M |
| Debt Repayment | (463M) | (155M) | (67M) | (471M) | (3.53B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (525M) | 0 | 0 | (1.25B) | (2.3B) |
| Dividends Paid | (1.76B) | (1.75B) | (1.42B) | (1.15B) | (1.11B) |
| Other Financing Activities | (313M) | (455M) | (121M) | (91M) | (239M) |
| Financing Cash Flow | (3.06B) | (2.36B) | (1.6B) | (2.95B) | (7.17B) |
| Effect of Forex Changes | (8M) | (30M) | (2M) | (158M) | (4M) |
| Net Change in Cash | (555M) | (2.15B) | 156M | 550M | 3.9B |
| Free Cash Flow | 2.63B | 1.09B | 97M | 2.96B | 7.3B |
Newmont Corporation
NYSE:NEM
Intrinsic Alpha fair value
Locked
Current Price
$104.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.